Teladoc Mergers and Acquisitions Presentation Deck
Endnotes
Page 7
1. Demonstrated at Fortune Brands after their Members spent 2 years enrolled in the
Livongo for Diabetes solution over a 6-week period in individuals with BP of at least 140/80
in a peer-reviewed study prepared by Livongo and presented to the American College of
Cardiology in April 2019; Average reduction in weight for Members who used Livongo's
solution for 12 months as of December 1, 2018; Depression Anxiety Stress Scale
improvement shown in 55% of Members from the time of enrollment as of March 31, 2019
Page 8
1. As of December 31, 2019.
2. $129 in medical savings plus supply cost savings (assumed to be $1 per test strip, used
once a day).
Page 9
1. US Virtual Care Visits To Soar To More Than 1 Billion, Forrester. 4/10/2020.
2. Telehealth: A quarter-trillion dollar post-COVID-19 reality?. McKinsey & Company,
5/29/2020.
3. Frost & Sullivan research.
4. CB Insights, as of 8/10/2020.
5. Mercom.
Page 10
1. Telehealth: A quarter-trillion dollar post-COVID-19 reality?. McKinsey & Company,
5/29/2020.
2. Sage Group Partners Survey, April 2020.
Teladoc Livongo®
HEALTH
3. Teladoc Brand Health, May 2020.
4. Business Group on Health Survey, August 2020.
Page 14
1. Annual visits calculated according to CDC reports from 2011, 2016, and 2017 of
ambulatory care visits in the US, which includes visits to physician offices, outpatient
hospital visits, ER, and other care locations
2. Based on Teladoc Health's internal analysis and industry data
3. Data from Teladoc Health's own business and estimates of visit fee (excludes PMPM
and dermatology)
4. Behavioral Health visits from 2018 SAMHSA report on mental illness
5. Incidence of top conditions currently addressed by Expert Medical team; data from
American Cancer Society (Cancers), Epilepsy Foundation (Epilepsy), Multiple Sclerosis
Foundation (MS), Crohn's and Colitis Foundation (IBD/Crohn's/ Colitis),
Gastroenterology and Hepatology (Diverticulitis), Best Practices and Research Clinical
Rheumatology (RA), US Bone and Joint Initiative (MSK conditions)
6. Based on Teladoc Health estimates of Expert Second Opinion case rate in market
7. Kaiser Family Foundation and American Association of Colleges of Nurses (AACN)
8. Internal estimates based on current pricing and market penetration
9. Endpoints calculated using AHA, CDC, NACHC
10. Number of diabetes patients covered by employer or Medicare and Medicaid sourced
from United Health Group
11. Livongo pricing
12. Number of hypertension patients (excluding those with diabetes or ~23.2 M people in
US) covered by employer or Medicare and Medicaid sourced from United Health Group
Teladoc Health, Inc. All rights reserved.
33View entire presentation